Having trouble viewing this email? View it as a Web page.
What’s New at CBER
You are subscribed to What’s New at CBER for the U.S. Food & Drug Administration (FDA).
This page has been updated recently.
- Summary Basis for Regulatory Action – ALBAclone Anti-Fyb (Human/Murine Monoclonal) (PDF – 119KB)
- July 7, 2017 Approval Letter – FluLaval Quadrivalent (PDF – 33KB)
- BK170059 – Trima Accel Automated Blood Collection System
- June 20, 2017 Summary Basis for Regulatory Action Template – ORTHO Sera (PDF – 278KB)